Paragon Biosciences is a life science innovator that creates, builds, and funds innovative biology-based companies. Paragon Biosciences focuses on identifying unmet needs in healthcare and developing solutions through its portfolio companies.

Paragon Biosciences

Paragon is a global life science leader that creates, builds and funds innovative biology-based companies. We use biology to accelerate scientific breakthroughs to solve some of society's most challenging medical problems.

Fantastic news from Harmony Biosciences! Congratulations!

Latest research from University of Michigan, the Weizman Institute of Science, and the University of Pennsylvania investigates the early stages of the human central nervous system (CNS). Having a deeper understanding of how the brain and spinal cord develop and communicate could lead to better treatment strategies for people living with CNS disorders.

Encouraged by the work of our portfolio company, Emalex Biosciences, to address a high unmet patient need.

Today, we honor the incredible dedication, compassion, and expertise of our nation's doctors who tirelessly serve patients and communities. Their impact extends far beyond the walls of hospitals, clinics and offices.

Today, we remember and celebrate the impact of visionary leader Dr. Martin Luther King Jr. who dedicated his life to equality, justice, and unity.  #martinlutherkingjr

May the light of the season shine throughout the year!

Congratulations Harmony Biosciences! Well deserved!

Expired or unused prescription medications pose a public safety risk. Safeguard lives and protect the environment by participating in #TakeBackDay on Sat., Oct. 28 from 10 a.m. – 2 p.m. (local time). 

Find a convenient collection site near you at www.DEATakeBack.com.

HSTS

CrUX Dataset

CrUX Top 50m

DigiCert SSL

SiteGround CAPTCHA

Executive Vice President, Legal Affairs and General Counsel

Pat Morris

Senior Vice President Business Development

Eric Messner

VP, Regulatory Affairs

Jenny Swalec

SVP, Research & Exploratory Development at Paragon Biosciences

Stephen Wanaski

Director of Communications

Evelyn O'Connor

Director of Accounting Operations

Fran Subotic

Director of Information Technology

Robert Fincannon

Director Corporate Communications

Sheridan Chaney

Manager HR Operations, Recruiting and Talent

Kathy Stoch

Office Manager

Yoryani Pena

Jeff Aronin

Founder, Chairman & CEO

Kevin Scoby

AVP - Portfolio Management

Accelerators with Investments in Greater Philadelphia Area

Great Lakes Companies With Less Than $50M in Revenue (Top 10K)

Pharmaceutical Companies With Fewer Than 1000 Employees (Top 10K)

Companies With Less Than $500M in Revenue (Top 10K)

Paragon Biosciences is a global healthcare company committed to accelerating biomedical research. It solves complex challenges by advancing science. Paragon focuses on four areas of life science innovation including artificial intelligence, gene therapy, synthetic biology, and biopharmaceuticals. Its current portfolio includes Castle Creek Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences, Qlarity Imaging, Skyline Biosciences, and a consistent flow of incubating companies in development. Paragon stands at the intersection of human need, life science, and company creation.

The company was founded in 2010 and is headquartered in Northbrook, Illinois.

Funding Round - Paragon Biosciences

Advertising, Business and Retail Services

Chicago

Illinois

United States

North America

The 10 Biggest Rounds Of November: Aspen Powers Up With $350M; DispatchHealth Raises Big For In-Home Care

What a time to be a new hospital CEO • Paragon Biosciences company gets $250M • Lurie's $25M health center

The Week’s 10 Biggest Funding Rounds: Biotech Leads The Way As Emalex And HI-Bio See Large Rounds

Emalex Raises $250M For Tourette Syndrome Treatment

India

Asia

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 31, 2024 2:37 PM	623d4019
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Oct 28, 2024 1:51 PM	5a71e4a3
crunchbase profile	general	Oct 29, 2024 9:16 AM	c3dd8227
li profile	general	Aug 31, 2024 2:37 PM	8019550f
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	8e631e77
peers	general	Aug 31, 2024 2:37 PM	8521a17e
news basic	general	Aug 31, 2024 2:37 PM	a65732b6
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

PARA

COM:PARAGONBIOSCI

Paragon Biosciences